Elutia (ELUT) Cost of Revenue (2019 - 2026)
Elutia (ELUT) reported Cost of Revenue of $1.3 million for Q1 2026, down 16.38% on a YoY basis from $1.6 million in Q1 2025, and down 3.32% sequentially from $1.4 million in Q4 2025.
Elutia (ELUT) Cost of Revenue (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Cost of Revenue data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue fell 16.38% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (down 12.84% YoY), and the FY2025 full-year result was $5.7 million, down 26.51% from the prior year.
- Cost of Revenue fell to $1.3 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $7.7 million in Q2 2022 to a low of $1.3 million in Q1 2026.
- A 5-year average of $3.2 million and a median of $3.2 million in 2025 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue slumped 62.67% in 2022 and increased 27.6% in 2024, its largest moves.
- Tracing ELUT's Cost of Revenue over 5 years: stood at $3.5 million in 2022, then grew by 6.48% to $3.7 million in 2023, then sank by 60.15% to $1.5 million in 2024, then slipped by 9.17% to $1.4 million in 2025, then declined by 3.32% to $1.3 million in 2026.
- Business Quant data shows ELUT's Cost of Revenue at $1.3 million in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 3.21 Mn |
| Jun 30, 2025 | 3.21 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 3.75 Mn |
| Dec 31, 2023 | 3.75 Mn |